Robustly interrogating machine learning-based scoring functions: what are they learning?
Durant G. et al, (2025), Bioinformatics, 41
Fragmenstein: predicting protein–ligand structures of compounds derived from known crystallographic fragment hits using a strict conserved-binding–based methodology
Ferla MP. et al, (2025), Journal of Cheminformatics, 17
EEFSEC deficiency: A selenopathy with early-onset neurodegeneration.
Laugwitz L. et al, (2025), American journal of human genetics, 112, 168 - 180
Toward target 2035: EUbOPEN - a public–private partnership to enable & unlock biology in the open
Tredup C. et al, (2025), RSC Medicinal Chemistry
Development of methodology to support molecular endotype discovery from synovial fluid of individuals with knee osteoarthritis: The STEpUP OA consortium
Deng Y. et al, (2024), PLOS ONE, 19, e0309677 - e0309677
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease.
Thomas T. et al, (2024), Nature immunology, 25, 2152 - 2165
Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements
Griffen EJ. and Boulet P., (2024), Wellcome Open Research, 9, 374 - 374
A data science roadmap for open science organizations engaged in early-stage drug discovery.
Edfeldt K. et al, (2024), Nature communications, 15
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Pouwels KB. et al, (2024), Nature Communications, 15
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study
Bešević J. et al, (2024), Journal of Epidemiology and Community Health, 78, 105 - 108
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases
Pagnamenta AT. et al, (2023), Genome Medicine, 15
Integrative GWAS and co-localisation analysis suggests novel genes associated with age-related multimorbidity
West CE. et al, (2023), Scientific Data, 10
Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes.
Thompson KN. et al, (2023), Science translational medicine, 15
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
Wei J. et al, (2023), Nature Communications, 14
Supportive Evidence For The Potential For Novel Biodiscovery In Osteoarthritis Through The Stepup Oa Consortium
Perry TA. et al, (2023), Osteoarthritis and Cartilage, 31, S353 - S354
COMBATdb: a database for the COVID-19 Multi-Omics Blood ATlas
Wang D. et al, (2023), Nucleic Acids Research, 51, D896 - D905
Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications
Aschenbrenner D. et al, (2022), Journal of Clinical Immunology
Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom
Vihta KD. et al, (2022), Clinical Infectious Diseases, 75, e329 - e337
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom
Vihta1 KD. et al, (2022), Clinical Infectious Diseases
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Wei J. et al, (2022), Nature Medicine, 28, 1072 - 1082